{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:32:12Z","timestamp":1794047532241,"version":"4.8.0"},"reference-count":108,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Since the first description of a patient with von Willebrand disease (VWD) back in 1926, significant advances have been made in understanding the biology of von Willebrand factor (VWF). Under normal conditions, in vivo biosynthesis of VWF is restricted to endothelial cells and megakaryocytes only. This biosynthesis involves complex post-translational modifications (including glycosylation and multimerization) which play a key role in enabling the hemostatic functions of VWF. As a result, VWF circulates in normal plasma as a series of heterogeneous multimers that can modulate tethering of platelets and primary hemostasis at sites of vascular injury. In addition, VWF also influences secondary hemostasis by serving as a chaperone molecule and protecting factor VIII from proteolysis and premature clearance. The molecular mechanisms underlying the pro-hemostatic functions of VWF have been comprehensively characterized. These insights serve to underpin the current classification of different VWD subtypes. Interestingly, accumulating evidence over the past decade has identified an array of new ligands that are able to bind to VWF. Consistent with these data, recent studies have further suggested a series of novel and non-hemostatic biological functions for VWF. These include potential roles for VWF in regulating inflammation, wound healing, angiogenesis and tumor cell metastasis. Further research in the coming years will be required to determine the clinical significance of these non-hemostatic roles of VWF. Defining the molecular mechanisms involved may offer exciting opportunities to develop novel anti-VWF targeted treatment approaches for important unmet clinical needs.<\/jats:p>","DOI":"10.3324\/haematol.2024.286029","type":"journal-article","created":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T19:57:28Z","timestamp":1767297448000},"page":"15-25","source":"Crossref","is-referenced-by-count":12,"title":["Structure and multiple functions of von Willebrand factor"],"prefix":"10.3324","volume":"111","author":[{"given":"Sandra L.","family":"Haberichter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"83050","doi-asserted-by":"crossref","unstructured":"Seidizadeh O, Eikenboom JCJ, Denis CV. von Willebrand disease. Nat Rev Dis Primers. 2024; 10(1):51.","DOI":"10.1038\/s41572-024-00536-8"},{"key":"83051","doi-asserted-by":"crossref","unstructured":"Lenting PJ, Christophe OD, Denis CV. von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends. Blood. 2015; 125(13):2019-2028.","DOI":"10.1182\/blood-2014-06-528406"},{"key":"83052","doi-asserted-by":"crossref","unstructured":"Turecek PL, Johnsen JM, Pipe SW, O\u2019Donnell JS, iPATH study group. Biological mechanisms underlying inter-individual variation in factor VIII clearance in haemophilia. Haemophilia. 2020; 26(4):575-583.","DOI":"10.1111\/hae.14078"},{"key":"83053","doi-asserted-by":"crossref","unstructured":"Pipe SW, Montgomery RR, Pratt KP, Lenting PJ, Lillicrap D. Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A. Blood. 2016; 128(16):2007-2016.","DOI":"10.1182\/blood-2016-04-713289"},{"key":"83054","doi-asserted-by":"crossref","unstructured":"Leebeek FW, Eikenboom JC. Von Willebrand\u2019s disease. N Engl J Med. 2016; 375(21):2067-2080.","DOI":"10.1056\/NEJMra1601561"},{"key":"83055","unstructured":"O\u2019Donnell J, Laffan M. Elevated plasma factor VIII levels--a novel risk factor for venous thromboembolism. Clin Lab. 2001; 47(1-2):1-6."},{"key":"83056","doi-asserted-by":"crossref","unstructured":"Sonneveld MA, de Maat MP, Leebeek FW. Von Willebrand factor and ADAMTS13 in arterial thrombosis: a systematic review and meta-analysis. Blood Rev. 2014; 28(4):167-178.","DOI":"10.1016\/j.blre.2014.04.003"},{"key":"83057","doi-asserted-by":"crossref","unstructured":"Ginsburg D, Handin RI, Bonthron DT. Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization. Science. 1985; 228(4706):1401-1406.","DOI":"10.1126\/science.3874428"},{"key":"83058","doi-asserted-by":"crossref","unstructured":"Zhou YF, Eng ET, Zhu J, Lu C, Walz T, Springer TA. Sequence and structure relationships within von Willebrand factor. Blood. 2012; 120(2):449-458.","DOI":"10.1182\/blood-2012-01-405134"},{"key":"83059","doi-asserted-by":"crossref","unstructured":"Atiq F, O\u2019Donnell JS. Novel functions for von Willebrand factor. Blood. 2024; 144(12):1247-1256.","DOI":"10.1182\/blood.2023021915"},{"key":"83060","doi-asserted-by":"crossref","unstructured":"Jaffe EA, Hoyer LW, Nachman RL. Synthesis of von Willebrand factor by cultured human endothelial cells. Proc Natl Acad Sci U S A. 1974; 71(5):1906-1909.","DOI":"10.1073\/pnas.71.5.1906"},{"key":"83061","doi-asserted-by":"crossref","unstructured":"Nachman R, Levine R, Jaffe EA. Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes. J Clin Invest. 1977; 60(4):914-921.","DOI":"10.1172\/JCI108846"},{"key":"83062","doi-asserted-by":"crossref","unstructured":"Jacobi PM, Gill JC, Flood VH, Jakab DA, Friedman KD, Haberichter SL. Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage. Blood. 2012; 119(19):4543-4553.","DOI":"10.1182\/blood-2011-06-360875"},{"key":"83063","doi-asserted-by":"crossref","unstructured":"Vischer UM, Wagner DD. von Willebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies. Blood. 1994; 83(12):3536-3544.","DOI":"10.1182\/blood.V83.12.3536.bloodjournal83123536"},{"key":"83064","doi-asserted-by":"crossref","unstructured":"Haberichter SL, Merricks EP, Fahs SA, Christopherson PA, Nichols TC, Montgomery RR. Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells. Blood. 2005; 105(1):145-152.","DOI":"10.1182\/blood-2004-02-0464"},{"key":"83065","doi-asserted-by":"crossref","unstructured":"Haberichter SL, Jacobi P, Montgomery RR. Critical independent regions in the VWF propeptide and mature VWF that enable normal VWF storage. Blood. 2003; 101(4):1384-1391.","DOI":"10.1182\/blood-2002-07-2281"},{"key":"83066","doi-asserted-by":"crossref","unstructured":"Haberichter SL, Fahs SA, Montgomery RR. von Willebrand factor storage and multimerization: 2 independent intracellular processes. Blood. 2000; 96(5):1808-1815.","DOI":"10.1182\/blood.V96.5.1808.h8001808_1808_1815"},{"key":"83067","doi-asserted-by":"crossref","unstructured":"Journet AM, Saffaripour S, Wagner DD. Requirement for both D domains of the propolypeptide in von Willebrand factor multimerization and storage. Thromb Haemost. 1993; 70(6):1053-1057.","DOI":"10.1055\/s-0038-1649724"},{"key":"83068","doi-asserted-by":"crossref","unstructured":"Wagner DD, Saffaripour S, Bonfanti R. Induction of specific storage organelles by von Willebrand factor propolypeptide. Cell. 1991; 64(2):403-413.","DOI":"10.1016\/0092-8674(91)90648-I"},{"key":"83069","doi-asserted-by":"crossref","unstructured":"Voorberg J, Fontijn R, van Mourik JA, Pannekoek H. Domains involved in multimer assembly of von Willebrand factor (vWF): multimerization is independent of dimerization. EMBO J. 1990; 9(3):797-803.","DOI":"10.1002\/j.1460-2075.1990.tb08176.x"},{"key":"83070","doi-asserted-by":"crossref","unstructured":"Mayadas TN, Wagner DD. In vitro multimerization of von Willebrand factor is triggered by low pH. Importance of the propolypeptide and free sulfhydryls. J Biol Chem. 1989; 264(23):13497-13503.","DOI":"10.1016\/S0021-9258(18)80024-2"},{"key":"83071","doi-asserted-by":"crossref","unstructured":"Li Y, Choi H, Zhou Z. Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions. J Thromb Haemost. 2008; 6(7):1135-1143.","DOI":"10.1111\/j.1538-7836.2008.02991.x"},{"key":"83072","doi-asserted-by":"crossref","unstructured":"Marti T, Rosselet SJ, Titani K, Walsh KA. Identification of disulfide-bridged substructures within human von Willebrand factor. Biochemistry. 1987; 26(25):8099-8109.","DOI":"10.1021\/bi00399a013"},{"key":"83073","doi-asserted-by":"crossref","unstructured":"Canis K, McKinnon TA, Nowak A. Mapping the N-glycome of human von Willebrand factor. Biochem J. 2012; 447(2):217-228.","DOI":"10.1042\/BJ20120810"},{"key":"83074","doi-asserted-by":"crossref","unstructured":"Hampton RY. ER-associated degradation in protein quality control and cellular regulation. Curr Opin Cell Biol. 2002; 14(4):476-482.","DOI":"10.1016\/S0955-0674(02)00358-7"},{"key":"83075","doi-asserted-by":"crossref","unstructured":"Bonifacino JS, Lippincott-Schwartz J. Degradation of proteins within the endoplasmic reticulum. Curr Opin Cell Biol. 1991; 3(4):592-600.","DOI":"10.1016\/0955-0674(91)90028-W"},{"key":"83076","doi-asserted-by":"crossref","unstructured":"Canis K, McKinnon TA, Nowak A. The plasma von Willebrand factor O-glycome comprises a surprising variety of structures including ABH antigens and disialosyl motifs. J Thromb Haemost. 2010; 8(1):137-145.","DOI":"10.1111\/j.1538-7836.2009.03665.x"},{"key":"83077","doi-asserted-by":"crossref","unstructured":"Ward S, O\u2019Sullivan JM, O\u2019Donnell JS. von Willebrand factor sialylation-a critical regulator of biological function. J Thromb Haemost. 2019; 17(7):1018-1029.","DOI":"10.1111\/jth.14471"},{"key":"83078","doi-asserted-by":"crossref","unstructured":"Aguila S, Lavin M, Dalton N. Increased galactose expression and enhanced clearance in patients with low von Willebrand factor. Blood. 2019; 133(14):1585-1596.","DOI":"10.1182\/blood-2018-09-874636"},{"key":"83079","doi-asserted-by":"crossref","unstructured":"Karampini E, Doherty D, Burgisser PE. O-glycan determinants regulate VWF trafficking to Weibel-Palade bodies. Blood Adv. 2024; 8(12):3254-3266.","DOI":"10.1182\/bloodadvances.2023012499"},{"key":"83080","doi-asserted-by":"crossref","unstructured":"Rehemtulla A, Kaufman RJ. Preferred sequence requirements for cleavage of pro-von Willebrand factor by propeptide-processing enzymes. Blood. 1992; 79(9):2349-2355.","DOI":"10.1182\/blood.V79.9.2349.2349"},{"key":"83081","doi-asserted-by":"crossref","unstructured":"Sadler JE, Budde U, Eikenboom JC. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost. 2006; 4(10):2103-2114.","DOI":"10.1111\/j.1538-7836.2006.02146.x"},{"key":"83082","doi-asserted-by":"crossref","unstructured":"Purvis AR, Gross J, Dang LT. Two Cys residues essential for von Willebrand factor multimer assembly in the Golgi. Proc Natl Acad Sci U S A. 2007; 104(40):15647-15652.","DOI":"10.1073\/pnas.0705175104"},{"key":"83083","doi-asserted-by":"crossref","unstructured":"Weibel ER, Palade GE. New cytoplasmic components in arterial endothelia. J Cell Biol. 1964; 23(1):101-112.","DOI":"10.1083\/jcb.23.1.101"},{"key":"83084","doi-asserted-by":"crossref","unstructured":"Cramer EM, Meyer D, le Menn R, Breton-Gorius J. Eccentric localization of von Willebrand factor in an internal structure of platelet alpha-granule resembling that of Weibel-Palade bodies. Blood. 1985; 66(3):710-713.","DOI":"10.1182\/blood.V66.3.710.bloodjournal663710"},{"key":"83085","doi-asserted-by":"crossref","unstructured":"Voorberg J, Fontijn R, Calafat J, Janssen H, van Mourik JA, Pannekoek H. Biogenesis of von Willebrand factor-containing organelles in heterologous transfected CV-1 cells. EMBO J. 1993; 12(2):749-758.","DOI":"10.1002\/j.1460-2075.1993.tb05709.x"},{"key":"83086","doi-asserted-by":"crossref","unstructured":"Hop C, Fontijn R, van Mourik JA, Pannekoek H. Polarity of constitutive and regulated von Willebrand factor secretion by transfected MDCK-II cells. Exp Cell Res. 1997; 230(2):352-361.","DOI":"10.1006\/excr.1996.3431"},{"key":"83087","doi-asserted-by":"crossref","unstructured":"Vischer UM, Wagner DD. CD63 is a component of Weibel-Palade bodies of human endothelial cells. Blood. 1993; 82(4):1184-1191.","DOI":"10.1182\/blood.V82.4.1184.1184"},{"key":"83088","doi-asserted-by":"crossref","unstructured":"Michaux G, Hewlett LJ, Messenger SL. Analysis of intracellular storage and regulated secretion of 3 von Willebrand disease-causing variants of von Willebrand factor. Blood. 2003; 102(7):2452-2458.","DOI":"10.1182\/blood-2003-02-0599"},{"key":"83089","doi-asserted-by":"crossref","unstructured":"Hommais A, Stepanian A, Fressinaud E. Mutations C1157F and C1234W of von Willebrand factor cause intracellular retention with defective multimerization and secretion. J Thromb Haemost. 2006; 4(1):148-157.","DOI":"10.1111\/j.1538-7836.2005.01652.x"},{"key":"83090","doi-asserted-by":"crossref","unstructured":"Denis C, Methia N, Frenette PS. A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci U S A. 1998; 95(16):9524-9529.","DOI":"10.1073\/pnas.95.16.9524"},{"key":"83091","doi-asserted-by":"crossref","unstructured":"Huang RH, Wang Y, Roth R. Assembly of Weibel-Palade body-like tubules from N-terminal domains of von Willebrand factor. Proc Natl Acad Sci U S A. 2008; 105(2):482-487.","DOI":"10.1073\/pnas.0710079105"},{"key":"83092","doi-asserted-by":"crossref","unstructured":"Kaufmann JE, Oksche A, Wollheim CB, Gunther G, Rosenthal W, Vischer UM. Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP. J Clin Invest. 2000; 106(1):107-116.","DOI":"10.1172\/JCI9516"},{"key":"83093","doi-asserted-by":"crossref","unstructured":"Wolff B, Burns AR, Middleton J, Rot A. Endothelial cell \u201cmemory\u201d of inflammatory stimulation: human venular endothelial cells store interleukin 8 in Weibel-Palade bodies. J Exp Med. 1998; 188(9):1757-1762.","DOI":"10.1084\/jem.188.9.1757"},{"key":"83094","doi-asserted-by":"crossref","unstructured":"Shahbazi S, Lenting PJ, Fribourg C, Terraube V, Denis CV, Christophe OD. Characterization of the interaction between von Willebrand factor and osteoprotegerin. J Thromb Haemost. 2007; 5(9):1956-1962.","DOI":"10.1111\/j.1538-7836.2007.02681.x"},{"key":"83095","doi-asserted-by":"crossref","unstructured":"van Mourik JA, Boertjes R, Huisveld IA. von Willebrand factor propeptide in vascular disorders: a tool to distinguish between acute and chronic endothelial cell perturbation. Blood. 1999; 94(1):179-185.","DOI":"10.1182\/blood.V94.1.179.413k18_179_185"},{"key":"83096","doi-asserted-by":"crossref","unstructured":"Lenting PJ, Denis CV, Christophe OD. How unique structural adaptations support and coordinate the complex function of von Willebrand factor. Blood. 2024; 144(21):2174-2184.","DOI":"10.1182\/blood.2023023277"},{"key":"83097","doi-asserted-by":"crossref","unstructured":"Padilla A, Moake JL, Bernardo A. P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface. Blood. 2004; 103(6):2150-2156.","DOI":"10.1182\/blood-2003-08-2956"},{"key":"83098","doi-asserted-by":"crossref","unstructured":"Huang J, Roth R, Heuser JE, Sadler JE. Integrin alpha(v)beta(3) on human endothelial cells binds von Willebrand factor strings under fluid shear stress. Blood. 2009; 113(7):1589-1597.","DOI":"10.1182\/blood-2008-05-158584"},{"key":"83099","doi-asserted-by":"crossref","unstructured":"Bridges DJ, Bunn J, van Mourik JA. Rapid activation of endothelial cells enables Plasmodium falciparum adhesion to platelet-decorated von Willebrand factor strings. Blood. 2010; 115(7):1472-1474.","DOI":"10.1182\/blood-2009-07-235150"},{"key":"83100","doi-asserted-by":"crossref","unstructured":"McGrath RT, McRae E, Smith OP, O\u2019Donnell JS. Platelet von Willebrand factor--structure, function and biological importance. Br J Haematol. 2010; 148(6):834-843.","DOI":"10.1111\/j.1365-2141.2009.08052.x"},{"key":"83101","doi-asserted-by":"crossref","unstructured":"Mannucci PM. Platelet von Willebrand factor in inherited and acquired bleeding disorders. Proc Natl Acad Sci U S A. 1995; 92(7):2428-2432.","DOI":"10.1073\/pnas.92.7.2428"},{"key":"83102","doi-asserted-by":"crossref","unstructured":"McGrath RT, van den Biggelaar M, Byrne B. Altered glycosylation of platelet-derived von Willebrand factor confers resistance to ADAMTS13 proteolysis. Blood. 2013; 122(25):4107-4110.","DOI":"10.1182\/blood-2013-04-496851"},{"key":"83103","doi-asserted-by":"crossref","unstructured":"Arce NA, Cao W, Brown AK. Activation of von Willebrand factor via mechanical unfolding of its discontinuous autoinhibitory module. Nat Commun. 2021; 12(1):2360.","DOI":"10.1038\/s41467-021-22634-x"},{"key":"83104","doi-asserted-by":"crossref","unstructured":"Arce NA, Markham-Lee Z, Liang Q. Conformational activation and inhibition of von Willebrand factor by targeting its autoinhibitory module. Blood. 2024; 143(19):1992-2004.","DOI":"10.1182\/blood.2023022038"},{"key":"83105","doi-asserted-by":"crossref","unstructured":"Deng W, Wang Y, Druzak SA. A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor. J Thromb Haemost. 2017; 15(9):1867-1877.","DOI":"10.1111\/jth.13775"},{"key":"83106","doi-asserted-by":"crossref","unstructured":"Chopek MW, Girma JP, Fujikawa K, Davie EW, Titani K. Human von Willebrand factor: a multivalent protein composed of identical subunits. Biochemistry. 1986; 25(11):3146-3155.","DOI":"10.1021\/bi00359a012"},{"key":"83107","doi-asserted-by":"crossref","unstructured":"Fogarty H, Doherty D, O\u2019Donnell JS. New developments in von Willebrand disease. Br J Haematol. 2020; 191(3):329-339.","DOI":"10.1111\/bjh.16681"},{"key":"83108","doi-asserted-by":"crossref","unstructured":"Flood VH, Gill JC, Morateck PA. Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor. Blood. 2010; 116(2):280-286.","DOI":"10.1182\/blood-2009-10-249102"},{"key":"83109","doi-asserted-by":"crossref","unstructured":"Phillips DR, Fitzgerald LA, Charo IF, Parise LV. The platelet membrane glycoprotein IIb\/IIIa complex. Structure, function, and relationship to adhesive protein receptors in nucleated cells. Ann N Y Acad Sci. 1987; 509:177-187.","DOI":"10.1111\/j.1749-6632.1987.tb30994.x"},{"key":"83110","doi-asserted-by":"crossref","unstructured":"Marx I, Christophe OD, Lenting PJ. Altered thrombus formation in von Willebrand factor-deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa. Blood. 2008; 112(3):603-609.","DOI":"10.1182\/blood-2008-02-142943"},{"key":"83111","doi-asserted-by":"crossref","unstructured":"Xu ER, von Bulow S, Chen PC. Structure and dynamics of the platelet integrin-binding C4 domain of von Willebrand factor. Blood. 2019; 133(4):366-376.","DOI":"10.1182\/blood-2018-04-843615"},{"key":"83112","doi-asserted-by":"crossref","unstructured":"Romijn RA, Bouma B, Wuyster W. Identification of the collagen-binding site of the von Willebrand factor A3-domain. J Biol Chem. 2001; 276(13):9985-9991.","DOI":"10.1074\/jbc.M006548200"},{"key":"83113","doi-asserted-by":"crossref","unstructured":"Huizinga EG, Martijn van der Plas R, Kroon J, Sixma JJ, Gros P. Crystal structure of the A3 domain of human von Willebrand factor: implications for collagen binding. Structure. 1997; 5(9):1147-1156.","DOI":"10.1016\/S0969-2126(97)00266-9"},{"key":"83114","doi-asserted-by":"crossref","unstructured":"Flood VH, Schlauderaff AC, Haberichter SL. Crucial role for the VWF A1 domain in binding to type IV collagen. Blood. 2015; 125(14):2297-2304.","DOI":"10.1182\/blood-2014-11-610824"},{"key":"83115","doi-asserted-by":"crossref","unstructured":"Flood VH, Gill JC, Christopherson PA. Critical von Willebrand factor A1 domain residues influence type VI collagen binding. J Thromb Haemost. 2012; 10(7):1417-1424.","DOI":"10.1111\/j.1538-7836.2012.04746.x"},{"key":"83116","doi-asserted-by":"crossref","unstructured":"Santoro SA. Preferential binding of high molecular weight forms of von Willebrand factor to fibrillar collagen. Biochim Biophys Acta. 1983; 756(1):123-126.","DOI":"10.1016\/0304-4165(83)90032-6"},{"key":"83117","doi-asserted-by":"crossref","unstructured":"Vlot AJ, Koppelman SJ, van den Berg MH, Bouma BN, Sixma JJ. The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor. Blood. 1995; 85(11):3150-3157.","DOI":"10.1182\/blood.V85.11.3150.bloodjournal85113150"},{"key":"83118","doi-asserted-by":"crossref","unstructured":"Dimitrov JD, Christophe OD, Kang J. Thermodynamic analysis of the interaction of factor VIII with von Willebrand factor. Biochemistry. 2012; 51(20):4108-4116.","DOI":"10.1021\/bi300232d"},{"key":"83119","doi-asserted-by":"crossref","unstructured":"Chiu PL, Bou-Assaf GM, Chhabra ES. Mapping the interaction between factor VIII and von Willebrand factor by electron microscopy and mass spectrometry. Blood. 2015; 126(8):935-938.","DOI":"10.1182\/blood-2015-04-641688"},{"key":"83120","doi-asserted-by":"crossref","unstructured":"Yee A, Oleskie AN, Dosey AM. Visualization of an N-terminal fragment of von Willebrand factor in complex with factor VIII. Blood. 2015; 126(8):939-942.","DOI":"10.1182\/blood-2015-04-641696"},{"key":"83121","doi-asserted-by":"crossref","unstructured":"Yee A, Gildersleeve RD, Gu S. A von Willebrand factor fragment containing the D\u2019D3 domains is sufficient to stabilize coagulation factor VIII in mice. Blood. 2014; 124(3):445-452.","DOI":"10.1182\/blood-2013-11-540534"},{"key":"83122","doi-asserted-by":"crossref","unstructured":"Crawley JT, de Groot R, Xiang Y, Luken BM, Lane DA. Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor. Blood. 2011; 118(12):3212-3221.","DOI":"10.1182\/blood-2011-02-306597"},{"key":"83123","doi-asserted-by":"crossref","unstructured":"Wang A, Liu F, Dong N. Thrombospondin-1 and ADAMTS13 competitively bind to VWF A2 and A3 domains in vitro. Thromb Res. 2010; 126(4):e260-265.","DOI":"10.1016\/j.thromres.2010.07.009"},{"key":"83124","doi-asserted-by":"crossref","unstructured":"Nazy I, Elliott TD, Arnold DM. Platelet factor 4 inhibits ADAMTS13 activity and regulates the multimeric distribution of von Willebrand factor. Br J Haematol. 2020; 190(4):594-598.","DOI":"10.1111\/bjh.16553"},{"key":"83125","doi-asserted-by":"crossref","unstructured":"Moake JL, Rudy CK, Troll JH. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med. 1982; 307(23):1432-1435.","DOI":"10.1056\/NEJM198212023072306"},{"key":"83126","doi-asserted-by":"crossref","unstructured":"Fogarty H, Ward SE, Townsend L. Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction. J Thromb Haemost. 2022; 20(10):2429-2438.","DOI":"10.1111\/jth.15830"},{"key":"83127","doi-asserted-by":"crossref","unstructured":"O\u2019Regan N, Gegenbauer K, O\u2019Sullivan JM. A novel role for von Willebrand factor in the pathogenesis of experimental cerebral malaria. Blood. 2016; 127(9):1192-1201.","DOI":"10.1182\/blood-2015-07-654921"},{"key":"83128","doi-asserted-by":"crossref","unstructured":"Dorner AJ, Bole DG, Kaufman RJ. The relationship of N-linked glycosylation and heavy chain-binding protein association with the secretion of glycoproteins. J Cell Biol. 1987; 105(6 Pt 1):2665-2674.","DOI":"10.1083\/jcb.105.6.2665"},{"key":"83129","doi-asserted-by":"crossref","unstructured":"Grewal PK, Uchiyama S, Ditto D. The Ashwell receptor mitigates the lethal coagulopathy of sepsis. Nat Med. 2008; 14(6):648-655.","DOI":"10.1038\/nm1760"},{"key":"83130","doi-asserted-by":"crossref","unstructured":"Ward SE, O\u2019Sullivan JM, Moran AB. Sialylation on O-linked glycans protects von Willebrand factor from macrophage galactose lectin-mediated clearance. Haematologica. 2022; 107(3):668-679.","DOI":"10.3324\/haematol.2020.274720"},{"key":"83131","doi-asserted-by":"crossref","unstructured":"Rydz N, Swystun LL, Notley C. The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels. Blood. 2013; 121(26):5228-5237.","DOI":"10.1182\/blood-2012-10-457507"},{"key":"83132","doi-asserted-by":"crossref","unstructured":"Rastegarlari G, Pegon JN, Casari C. Macrophage LRP1 contributes to the clearance of von Willebrand factor. Blood. 2012; 119(9):2126-2134.","DOI":"10.1182\/blood-2011-08-373605"},{"key":"83133","doi-asserted-by":"crossref","unstructured":"Wohner N, Muczynski V, Mohamadi A. Macrophage scavenger receptor SR-AI contributes to the clearance of von Willebrand factor. Haematologica. 2018; 103(4):728-737.","DOI":"10.3324\/haematol.2017.175216"},{"key":"83134","doi-asserted-by":"crossref","unstructured":"Swystun LL, Lai JD, Notley C. The endothelial cell receptor stabilin-2 regulates VWF-FVIII complex half-life and immunogenicity. J Clin Invest. 2018; 128(9):4057-4073.","DOI":"10.1172\/JCI96400"},{"key":"83135","doi-asserted-by":"crossref","unstructured":"O\u2019Sullivan JM, Preston RJ, O\u2019Regan N, O\u2019Donnell JS. Emerging roles for hemostatic dysfunction in malaria pathogenesis. Blood. 2016; 127(19):2281-2288.","DOI":"10.1182\/blood-2015-11-636464"},{"key":"83136","doi-asserted-by":"crossref","unstructured":"Chen J, Hobbs WE, Le J, Lenting PJ, de Groot PG, Lopez JA. The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma. Blood. 2011; 117(13):3680-3683.","DOI":"10.1182\/blood-2010-08-302539"},{"key":"83137","doi-asserted-by":"crossref","unstructured":"Ward SE, Curley GF, Lavin M. Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activation. Br J Haematol. 2021; 192(4):714-719.","DOI":"10.1111\/bjh.17273"},{"key":"83138","doi-asserted-by":"crossref","unstructured":"Pendu R, Terraube V, Christophe OD. P-selectin glycoprotein ligand 1 and beta2-integrins cooperate in the adhesion of leukocytes to von Willebrand factor. Blood. 2006; 108(12):3746-3752.","DOI":"10.1182\/blood-2006-03-010322"},{"key":"83139","doi-asserted-by":"crossref","unstructured":"Petri B, Broermann A, Li H. von Willebrand factor promotes leukocyte extravasation. Blood. 2010; 116(22):4712-4719.","DOI":"10.1182\/blood-2010-03-276311"},{"key":"83140","doi-asserted-by":"crossref","unstructured":"Hillgruber C, Steingraber AK, Poppelmann B. Blocking von Willebrand factor for treatment of cutaneous inflammation. J Invest Dermatol. 2014; 134(1):77-86.","DOI":"10.1038\/jid.2013.292"},{"key":"83141","doi-asserted-by":"crossref","unstructured":"van Schooten CJ, Shahbazi S, Groot E. Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in vivo. Blood. 2008; 112(5):1704-1712.","DOI":"10.1182\/blood-2008-01-133181"},{"key":"83142","doi-asserted-by":"crossref","unstructured":"Chion A, O\u2019Sullivan JM, Drakeford C. N-linked glycans within the A2 domain of von Willebrand factor modulate macrophage-mediated clearance. Blood. 2016; 128(15):1959-1968.","DOI":"10.1182\/blood-2016-04-709436"},{"key":"83143","doi-asserted-by":"crossref","unstructured":"Drakeford C, Aguila S, Roche F. von Willebrand factor links primary hemostasis to innate immunity. Nat Commun. 2022; 13(1):6320.","DOI":"10.1038\/s41467-022-33796-7"},{"key":"83144","doi-asserted-by":"crossref","unstructured":"O\u2019Sullivan JM, Ward S, Lavin M, O\u2019Donnell JS. von Willebrand factor clearance - biological mechanisms and clinical significance. Br J Haematol. 2018; 183(2):185-195.","DOI":"10.1111\/bjh.15565"},{"key":"83145","doi-asserted-by":"crossref","unstructured":"Sorvillo N, Hartholt RB, Bloem E. von Willebrand factor binds to the surface of dendritic cells and modulates peptide presentation of factor VIII. Haematologica. 2016; 101(3):309-318.","DOI":"10.3324\/haematol.2015.137067"},{"key":"83146","doi-asserted-by":"crossref","unstructured":"Grassle S, Huck V, Pappelbaum KI. von Willebrand factor directly interacts with DNA from neutrophil extracellular traps. Arterioscler Thromb Vasc Biol. 2014; 34(7):1382-1389.","DOI":"10.1161\/ATVBAHA.113.303016"},{"key":"83147","doi-asserted-by":"crossref","unstructured":"Feng S, Liang X, Cruz MA. The interaction between factor H and von Willebrand factor. PLoS One. 2013; 8(8):e73715.","DOI":"10.1371\/journal.pone.0073715"},{"key":"83148","doi-asserted-by":"crossref","unstructured":"Nolasco JG, Nolasco LH, Da Q. Complement component C3 binds to the A3 domain of von Willebrand factor. TH Open. 2018; 2(3):e338-e345.","DOI":"10.1055\/s-0038-1672189"},{"key":"83149","doi-asserted-by":"crossref","unstructured":"Randi AM, Laffan MA. Von Willebrand factor and angiogenesis: basic and applied issues. J Thromb Haemost. 2017; 15(1):13-20.","DOI":"10.1111\/jth.13551"},{"key":"83150","doi-asserted-by":"crossref","unstructured":"Starke RD, Ferraro F, Paschalaki KE. Endothelial von Willebrand factor regulates angiogenesis. Blood. 2011; 117(3):1071-1080.","DOI":"10.1182\/blood-2010-01-264507"},{"key":"83151","doi-asserted-by":"crossref","unstructured":"Starke RD, Paschalaki KE, Dyer CE. Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells. Blood. 2013; 121(14):2773-2784.","DOI":"10.1182\/blood-2012-06-435727"},{"key":"83152","doi-asserted-by":"crossref","unstructured":"Ishihara J, Ishihara A, Starke RD. The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing. Blood. 2019; 133(24):2559-2569.","DOI":"10.1182\/blood.2019000510"},{"key":"83153","doi-asserted-by":"crossref","unstructured":"Lagrange J, Worou ME, Michel JB. The VWF\/LRP4\/ alphaVbeta3-axis represents a novel pathway regulating proliferation of human vascular smooth muscle cells. Cardiovasc Res. 2022; 118(2):622-637.","DOI":"10.1093\/cvr\/cvab042"},{"key":"83154","doi-asserted-by":"crossref","unstructured":"Baud\u2019huin M, Duplomb L, Teletchea S. Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival. J Biol Chem. 2009; 284(46):31704-31713.","DOI":"10.1074\/jbc.M109.030312"},{"key":"83155","doi-asserted-by":"crossref","unstructured":"Dhami SPS, Patmore S, Comerford C. Breast cancer cells mediate endothelial cell activation, promoting von Willebrand factor release, tumor adhesion, and transendothelial migration. J Thromb Haemost. 2022; 20(10):2350-2365.","DOI":"10.1111\/jth.15794"},{"key":"83156","doi-asserted-by":"crossref","unstructured":"O\u2019Sullivan JM, Preston RJS, Robson T, O\u2019Donnell JS. Emerging roles for von Willebrand factor in cancer cell biology. Semin Thromb Hemost. 2018; 44(2):159-166.","DOI":"10.1055\/s-0037-1607352"},{"key":"83157","doi-asserted-by":"crossref","unstructured":"Terraube V, Pendu R, Baruch D. Increased metastatic potential of tumor cells in von Willebrand factor-deficient mice. J Thromb Haemost. 2006; 4(3):519-526.","DOI":"10.1111\/j.1538-7836.2005.01770.x"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.286029\/79195","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.286029\/79257","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/13053\/79195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:10:45Z","timestamp":1794046245000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2024.286029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2024.286029","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,11]]}}}